AKT1 and cancer: One of the critical downstream targets of the PI3K/Akt pathway is the mammalian target of the rapamycin (mTOR) signalling pathway, which positively regulates cell growth (through the tight rotation of the lipid metabolism pathway, which is an essential process for cancer growth) and proliferation by promoting protein synthesis and the inhibition of autophagy [81].